Michael Maeng Selected Research

Biomarkers (Surrogate Marker)

2/2015

Safety of therapeutic hypothermia combined with primary percutaneous coronary intervention after out-of-hospital cardiac arrest.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Maeng Research Topics

Disease

71	Myocardial Infarction 11/2022 - 05/2004
64	Thrombosis (Thrombus) 06/2022 - 10/2006
36	Death (Near-Death Experience) 06/2022 - 10/2006
30	ST Elevation Myocardial Infarction 01/2022 - 07/2006
29	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 10/2006
19	Hemorrhage 11/2022 - 04/2014
18	Diabetes Mellitus 01/2022 - 07/2008
17	Coronary Artery Disease (Coronary Atherosclerosis) 11/2022 - 02/2009
11	Ischemic Stroke 11/2022 - 03/2012
10	Acute Coronary Syndrome 03/2022 - 10/2012
10	Stroke (Strokes) 01/2021 - 04/2014
9	Atrial Fibrillation 10/2022 - 10/2017
9	Pathologic Constriction (Stenosis) 11/2020 - 10/2003
6	Hyperplasia 01/2022 - 07/2008
6	Infarction (Infarctions) 01/2017 - 05/2004
4	Heart Failure 01/2022 - 01/2017
4	Myocardial Ischemia (Ischemic Heart Diseases) 07/2009 - 09/2003
4	Coronary Occlusion 09/2005 - 01/2003
3	Peripheral Arterial Disease 10/2022 - 10/2019
3	Stable Angina 12/2021 - 10/2012
3	Coronary Stenosis (Coronary Artery Stenosis) 01/2018 - 01/2010
3	Ischemia 07/2009 - 03/2006
2	Atherosclerotic Plaque (Atheroma) 10/2022 - 11/2020
2	Thromboembolism 10/2022 - 01/2020
2	Coronary Disease (Coronary Heart Disease) 12/2021 - 02/2016
2	COVID-19 01/2021 - 10/2020
2	Angina Pectoris 05/2019 - 08/2012
2	Type 2 Diabetes Mellitus (MODY) 01/2019 - 07/2009
2	Non-ST Elevated Myocardial Infarction 01/2019 - 09/2012
2	Embolism (Embolus) 01/2019 - 10/2017
2	Neointima 01/2018 - 09/2004
1	Liver Diseases (Liver Disease) 10/2022
1	Heart Diseases (Heart Disease) 01/2022
1	Atherosclerosis 01/2022
1	Dementia (Dementias) 01/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2021
1	Human Influenza (Influenza) 10/2020
1	Pneumonia (Pneumonitis) 10/2020
1	Mental Disorders (Mental Disorder) 08/2017
1	Spasm (Spasms) 01/2016
1	Out-of-Hospital Cardiac Arrest 02/2015
1	Pain (Aches) 06/2014
1	Vascular Remodeling 05/2014
1	Bundle-Branch Block (Fascicular Block) 10/2013

Drug/Important Bio-Agent (IBA)

25	omega-Chloroacetophenone (Mace)IBA 11/2022 - 05/2011
25	Sirolimus (Rapamycin)FDA Link 01/2022 - 07/2008
11	Everolimus FDA Link 03/2022 - 03/2012
9	Clopidogrel (Plavix)FDA Link 03/2022 - 03/2012
9	zotarolimusIBA 01/2020 - 03/2010
8	MetalsIBA 06/2022 - 07/2007
7	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2022 - 10/2017
6	Paclitaxel (Taxol)FDA LinkGeneric 10/2011 - 07/2008
5	PolymersIBA 01/2022 - 02/2013
5	Pharmaceutical PreparationsIBA 01/2022 - 07/2007
4	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022 - 01/2016
4	BESIBA 01/2022 - 01/2019
3	CalciumIBA 10/2022 - 12/2021
3	TicagrelorIBA 03/2022 - 10/2017
3	Warfarin (Coumadin)FDA LinkGeneric 12/2021 - 10/2017
3	Dabigatran FDA Link 12/2021 - 10/2017
3	Phenobarbital (Luminal)FDA Link 03/2016 - 10/2003
2	Vitamin K FDA Link 10/2022 - 01/2022
2	AnticoagulantsIBA 10/2022 - 03/2019
2	insulin receptor-related receptor (IRR)IBA 01/2022 - 01/2019
2	N- acetyl- S- (alpha- methyl- 4- (2- methylpropyl)benzeneacetyl)cysteine 4-(nitrooxy)butyl esterIBA 12/2021 - 10/2017
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 10/2020
2	Angiotensin Receptor AntagonistsIBA 01/2021 - 10/2020
2	Insulin (Novolin)FDA Link 01/2021 - 01/2019
2	Stainless Steel (Steel, Stainless)IBA 01/2020 - 01/2019
2	Tissue Plasminogen Activator (Alteplase)FDA Link 07/2009 - 05/2008
2	Erythropoietin FDA Link 09/2006 - 09/2005
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2022
1	eicosapentaenoic acid ethyl esterIBA 10/2022
1	Triglycerides (Triacylglycerol)IBA 10/2022
1	LDL CholesterolIBA 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	LipidsIBA 11/2020
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 10/2020
1	salicylhydroxamic acid (SHAM)IBA 10/2019
1	RivaroxabanIBA 10/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2017
1	Hemostatics (Antihemorrhagics)IBA 05/2016
1	Biomarkers (Surrogate Marker)IBA 02/2015

Therapy/Procedure

88	Stents 06/2022 - 10/2003
44	Percutaneous Coronary Intervention 04/2022 - 07/2006
25	Drug-Eluting Stents 04/2022 - 11/2008
24	Therapeutics 04/2022 - 05/2004
5	Catheters 11/2020 - 01/2003
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2021 - 10/2013
3	Thrombectomy 01/2020 - 07/2006
3	Patient Readmission 01/2020 - 09/2014
2	Surgical Amputation (Amputations) 10/2022 - 01/2021
2	Operative Surgical Procedures 12/2021 - 01/2019
1	Myocardial Revascularization 01/2018
1	Ischemic Postconditioning 01/2017
1	Heart Transplantation (Grafting, Heart) 01/2016
1	Treatment Delay 12/2015
1	Induced Hypothermia 02/2015
1	Vascular Closure Devices 06/2014